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A B S T R A C T   
The increasing incidence of antimicrobial resistance represents a global threat. As a result, surveillance pro-
grammes monitoring antimicrobial consumption and resistance in animals have been implemented in several 
countries throughout the world. However, such programmes depend on the accurate and detailed collection of 
data on antimicrobial consumption. For this reason, the aim of this longitudinal study was to compare the 
consistency of data on antimicrobial consumption between three different data collection methods. 
Antimicrobial consumption data associated to udder health were collected from 20 veterinary practices and 92 
dairy farms for 18 months. The compared data sources were: 1) data extracted from veterinary practice software 
2) farm treatment journals and 3) on-farm discarded drug packages (garbage). Two different procedures were 
chosen to analyse the data issued from treatment journals: 1) only complete entries were analysed 2) entries with 
missing dosage were supplemented with the information provided by the Swiss Compendium of Veterinary 
Medicinal Products. The antimicrobial data were divided into intramammary preparations used during lactation 
(IMM), intramammary preparations used for dry off (DRY) and systemic treatments (SYS). We compared the 
quantities of injectors (IMM and DRY), the quantities of active substances (SYS) and the treatment incidences (TI) 
for the defined daily dose (DDD) per 1000 cow-days (IMM and SYS) and the defined course dose (DCD) per 1000 
cow-days (DRY). Additionally, the variety of antimicrobial products among the different data sources was 
compared. 
The highest quantity of antimicrobials for IMM, DRY and SYS could be collected with the software data. The 
lowest quantity was collected by using the data of the treatment journal with only complete entries. For IMM and 
DRY, software and garbage performed similar, with agreement on the number of injectors used in 56.1% of the 
analysed cases. The widest variety of intramammary antimicrobial preparations was found in the garbage whilst 
most systemic preparations were collected using software data. The results of the study show a lack of data 
consistency between the three different data sources. None of the methods was able to collect the integral 
antimicrobial consumption in the participating farms. Finally, the results emphasise the need to implement a 
standardised system to quantify and assess the antimicrobial consumption at veterinary practice and farm level.   
1. Introduction 
Antimicrobial resistance (AMR) represents an undeniable threat to 
Public Health (Ferri et al., 2017). As inappropriate antimicrobial usage 
(AMU) is reinforcing AMR (Hoelzer et al., 2017), one important 
approach towards combatting this issue is the prudent and responsible 
use of antimicrobials. For this aim, good surveillance systems need to be 
in place. 
In April 2010, the European Medicines Agency (EMA) launched a 
project to develop a harmonised approach for the recording and 
reporting of AMU data in animals. This European Surveillance of Vet-
erinary Antimicrobial Consumption (ESVAC) project aims at collecting 
sales data of veterinary antimicrobials, allowing the European Union 
Member States and the European Economic Area to enhance policies on 
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AMU in veterinary medicine. Furthermore, the EMA published in 
February 2018 guidelines for reporting data on antimicrobial con-
sumption by animal species. These data allow the identification of 
species with the highest AMU and the monitoring and tracking of AMU 
within a given species. In addition, benchmarking of farms is possible, 
and use of antimicrobials in species for which they are not licensed can 
be identified (Edo, 2017; European Medicines Agency, 2020). 
At international level, several countries implemented monitoring 
systems to quantify antimicrobial consumption in food animals (Bager, 
2000; Veterinary Medicines Directorate, 2018; The Netherlands Veter-
inary Medicines Institute (SDa), 2020; AACTING, 2020; Government of 
Canada, 2020). These systems are based on either voluntary or 
mandatory records of antimicrobial usage from different stakeholders. 
Most of the time, veterinarians are the ones who report antimicrobial 
prescriptions (AMP) intended for diseased animals. However, feed mills, 
pharmaceutical companies, pharmacies as well as farmers also 
contribute to the antimicrobial data collection. Only very few systems 
use veterinary prescriptions extracted from the practice management 
software as an information base. All these aspects make the different 
monitoring systems inconsistent and not comparable (AACTING, 2020). 
Even within the same country, there can be large discrepancies between 
different data sources on antimicrobial consumption (Spycher et al., 
2002). 
In Switzerland, the National Strategy on Antibiotic Resistance (StAR) 
was launched in 2015 (Nationale Strategie Antibiotikaresistenzen 
Schweiz (StAR), 2015) with the aim to prevent the development and the 
spread of AMR. One strategic approach was to establish and monitor the 
consumption of antimicrobials on a comprehensive basis. At the time of 
this study, the only estimation of antimicrobial data in veterinary 
medicine was based on antimicrobial sales provided by the Marketing 
Authorization Holders and published annually in the ARCH-Vet-Report 
from the Federal Food Safety and Veterinary Office (FSVO) (Federal 
Food Safety and Veterinary Office, 2017). 
Under Swiss legislation, antimicrobials for animal treatments may 
only be prescribed and sold by veterinarians. If farmers want to 
administer antimicrobials to animals, they need to have a veterinary 
medicines contract with a veterinarian who performs regular farm visits. 
Furthermore, only antimicrobials for treatment of individual animals or 
groups of animals for a defined indication for a maximum duration of 
three months may be stored on the farm. Since 2016, on-farm storing of 
antimicrobials used for prophylactic treatments as well as Highest Pri-
ority Critically Important Antimicrobials (HPCIAs), except essential 
HPCIA quantities for ongoing treatments, is prohibited by law (Ver-
ordnung über die Tierarzneimittel (TAMV) AS 2016 97 961, 2016). 
Pharmacies may not sell antimicrobials directly to farmers without a 
prescription by a veterinarian. Prescription can be done electronically or 
on paper, and data on prescriptions are not assembled centrally. How-
ever, the legislation in Switzerland requires a precise documentation of 
AMU at farm level in the form of a treatment journal, indicating the date, 
animal identification number, treatment indication/diagnosis, sub-
stance, dosage, treatment duration and withdrawal period. The farmer 
has the responsibility and duty to keep the treatment journal up to date 
and to store it for three years (Verordnung über die Tierarzneimittel 
(TAMV) SR 812.212.27, 2004). At the time of data collection for this 
study, this could be done electronically or on paper. Since 2019, all 
antimicrobial treatments need to be recorded in a national database 
(Federal Food Safety and Veterinary Office, 2020). 
Switzerland had the highest sale (in weight of active substances) of 
intramammary antimicrobial preparations per population correction 
unit (biomass of livestock and slaughtered animals) in 2015 and 2016 in 
comparison to 29 other European countries (Wagemann, 2005; Euro-
pean Medicines Agency, 2017, 2018; Bundesamt für Statistik, 2018; 
Swissmilk, 2018). These antimicrobial preparations are used for the 
treatment of mastitis and dry cow therapy, which are the most common 
indications for AMU in dairy farms (Thomson et al., 2008; Menéndez 
González et al., 2010; De Briyne et al., 2014; Kuipers et al., 2015). For 
this reason, there is a special interest to quantify and monitor the actual 
AMU for both intramammary and systemic treatments of mastitis in 
Switzerland, requiring an accurate record of AMU at practice and farm 
level. Data quality of recording systems can best be assessed by 
comparing different methods of recording, on farm level as well as on 
veterinary practice level. Data on AMU in dairy farms can also be 
collected by analysing discarded drug packages, which has the advan-
tage that the farmer does not need to keep written records (Nobrega 
et al., 2017). 
Therefore, the aim of the study was to compare the data consistency 
between three different data collection methods: 1) data from the vet-
erinary practice software 2) farm treatment journal and 3) on-farm 
collection of discarded drug packages. 
2. Material und methods 
2.1. Study population 
Twenty-one veterinary practices were recruited in Switzerland dur-
ing a previous study (Pucken et al., 2019). Participating practices were 
informed about the project through newsletters in January 2016 via the 
Swiss Cattle Health Service and a newspaper article published in the 
Swiss Archive for Veterinary Medicine (Pucken et al., 2016). In addition, 
the project was presented at the continuous education for farm animal 
practitioners in Berne and Zurich in January 2016. Eligible veterinarians 
had to be members of the Swiss Association for Ruminant Health and 
had to work with one of the three most common veterinary practice 
management software to allow automated extraction of prescription 
data. Veterinarians were asked to provide a list of all eligible dairy cli-
ents having a veterinary medicines contract with the practice. This 
contract ensures that the veterinarian is the main farm veterinarian and 
performs regular farm visits. Five farms per veterinarian were then 
selected using the random number function of Excel. Farmers who 
refused participation (29), did not answer (14) or were not eligible for 
the study (9) were replaced with the next farmer on the list. In total 105 
dairy farms participated at the beginning of the study (Nägele et al., 
2019). 
2.2. Data collection and cleaning 
From August 2016 until January 2018 (18 months), data on anti-
microbial sales and use were collected with three different methods: 
data extracted from veterinary practice software, discarded drug pack-
ages collected on farms (from custom garbage bins on the farms) and 
farm treatment journals. The participating veterinarians and farmers 
signed an agreement allowing the authors to collect antimicrobial data 
from the different data sources. In order to record the collected data, 
spreadsheets were prepared (Microsoft Excel, Microsoft Corp., Red-
mond, WA), with the identity of the participating farmers, the months of 
data collection and a list of all antimicrobial products approved in 
Switzerland for mastitis treatment. If antimicrobials not yet included in 
the table were found in the data sources, the list was complemented with 
these. The data from every collection source was cleaned according to 
defined rules available as supplementary material (see Supplementary 
Material Fig. S1-S5). 
2.2.1. Data from practice software 
The participating veterinary practices were asked to share the files of 
all prescriptions and treatments for cattle of the participating five clients 
for the collection period. The data were provided either as PDF files or as 
Excel spreadsheets or on paper. 
Six veterinary practices preselected the provided software files. 
These files either only contained the prescribed antimicrobials used for 
mastitis treatment or the antimicrobials prescribed for mastitis treat-
ment were marked. In the second case, only the marked ones were 
considered. For the other practices, one of the authors (FMS) scanned 
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each file individually and each antimicrobial used for udder health was 
identified. The information considered from the software files was the 
following: date of prescription, name of the drug prescribed, amount of 
drug prescribed and the cow identification number, if present. System-
ically administered antimicrobials approved in Switzerland for mastitis 
treatment were considered if they were allocated to a clearly identified 
cow diagnosed with mastitis, or if it was declared as being used for 
mastitis treatment. If no indication was given, it was strictly decided 
according to the decision tree available in the supplementary material 
whether the drug was considered or not (see Supplementary Material 
Fig. S1). In case of any ambiguity regarding the amount of antimicro-
bials prescribed or the treatment indication, the respective veterinarian 
was contacted for verification (see Supplementary Material Fig. S2). 
Previously dispensed antimicrobials subsequently returned to the 
veterinarian were removed from the dataset. If a drug was identified as 
not being registered for mastitis or if a drug was used in a manner 
contrary to its approved method of application, it was not considered 
due to off-label use. Even though information on off label use is relevant, 
the number of off label treatments was too small to allow for a mean-
ingful comparison between the data sources. 
2.2.2. Discarded antimicrobial drug packages from garbage bins 
Eight-litre receptacles with swing and flap tops (Robert Thoma 
GmbH, 79733 Görwihl, Germany) and 20 suitable 10-litre garbage bags 
were placed on each of the participating farms for the collection of 
discarded antimicrobial packages (tubes, bottles, syringes). Farmers 
were asked to put the empty packages of all antimicrobials used for 
mastitis treatment into these bags, including dry cow treatments and 
drugs given as parenteral treatment for mastitis, regardless of the person 
who administered the antimicrobial. One garbage bag, labelled with the 
name of the farmer, the address of the farm, and the month of collection 
was provided for every month of data collection. In addition, two spare 
garbage bags were given as replacements. The bags were exchanged on 
the first day of every month by the farmer during the collection period. 
In order to ensure the monthly bag replacement, a reminder via phone or 
text message was sent to the farmer. The filled bags were collected in 
December 2016, July 2017 and February 2018 and the gathered drug 
packages were recorded in the corresponding spreadsheet. Intra-
mammary injectors were counted and the volumes of systemic prepa-
rations were summed. If an empty bottle or syringe was found in one of 
these bags, the data of amount used was supplemented either with the 
information given in the treatment journal or according to the infor-
mation given from the Swiss Compendium of Veterinary Medicinal 
Products (Swiss Compendium of Veterinary Medicinal Products, 2020). 
A decision tree was created to ensure that all data was entered uniformly 
(see Supplementary Material Fig. S3 and Fig. S4). 
2.2.3. Treatment journal 
In addition to the collection of discarded drug packages, the data of 
the treatment journals were analysed. The treatment journals were 
available either in electronic or paper format and were collected as 
photocopies or photographed. 
Only entries clearly assigned to mastitis treatment were considered. 
If the cow treatment was carried out across two months, all related 
medications were assigned to the first month (of treatment). Entries with 
missing drug names were discarded. In addition, missing cow identifi-
cation number(s) and missing prescription date(s) were ignored. If the 
dose was missing, but all other relevant information was available, two 
different procedures were chosen to handle this missing data. Each 
procedure ended in a separate spreadsheet, and was therefore regarded 
as a separate method of data collection. (1) The entry was deleted and 
therefore not further included in the database. This data source is 
referred to as treatment journal. (2) Either the drug was also found in the 
garbage bag and the entry was supplemented with the garbage dosage, 
or the drug was not found in the garbage and the entry was added with 
the information provided by the Swiss Compendium of Veterinary 
Medicinal Products (Swiss Compendium of Veterinary Medicinal Prod-
ucts, 2020). This data source is referred to as treatment journal added. If 
the dose was missing for intramammary antimicrobials used during 
lactation, one udder quarter was considered as affected and treated. If 
the dose was missing for intramammary antimicrobials used for dry off, 
the entire udder (both front and hind quarters) was considered as 
treated. If the Swiss Compendium of Veterinary Medicinal Products 
proposed different treatment protocols for different types of mastitis, the 
most common mastitis type was taken into account. If several treatment 
days were indicated, the shortest treatment duration was chosen (see 
Supplementary Material Fig. S5) (Swiss Compendium of Veterinary 
Medicinal Products, 2020). 
2.3. Analysis 
The collected data on antimicrobials were classified into three 
groups according to their indication and application route: intra-
mammary antimicrobials used during lactation (IMM), intramammary 
antimicrobials used for dry off (DRY) and antimicrobials used for sys-
temic treatment (SYS). In addition, the antimicrobials were grouped into 
three different categories based on the WHO list of Critically Important 
Antimicrobials for Human Medicine (WHO CIA list): Highest Priority 
Critically Important Antimicrobials (HPCIAs), High Priority Critically 
Important Antimicrobials (CIAs) and Highly Important Antimicrobials 
(HIAs) (WHO | Critically important antimicrobials for human medicine, 
6th revision, 2018). 
2.3.1. Comparison of antimicrobial quantities and antimicrobial products 
We compared the quantity of antimicrobials between the three 
different data sources: 1) data from the practice software (software); 2) 
discarded drug packages from garbage bins (garbage); 3) treatment 
journal and 4) treatment journal added. The quantity was measured by 
the total number of injectors (IMM and DRY), the quantity (in mg) of 
active substances (SYS) and in a standardised manner by calculating 
the treatment incidence (TI) for the defined daily dose (DDDvet) per 
1,000 cow-days (IMM and SYS) and the defined course dose (DCDvet) 
per 1,000 cow-days (DRY). As the TI can be used to consider times with 
varying population size, it provides a more precise picture of the 
population under study (Werner et al., 2018). The formula of More 
et al. (2017) was amended in this study for the calculation of TI for 
intramammary antimicrobials (More et al., 2017). For intramammary 
products for lactating cows, the unit for the DDDvet is unit dose per 
teat (UD/teat). As one quarter per cow affected by mastitis was 
assumed, this corresponds to one injector per cow per day. For dry cow 
treatments, the unit for the DCDvet is unit dose per udder (UD/udder), 
which corresponds to four injectors per cow (European Surveillance of 
Veterinary Antimicrobial Consumption (ESVAC), 2016). For systemic 
antimicrobials, the formula used by Svetlana et al. (2019) was modi-
fied (Kasabova et al., 2019). An estimated standard body weight for a 
cow was chosen at 600 kg (Menéndez González et al., 2010). The 
observation period was set at 549 days. The number of cows on each 
farm was determined at the beginning of the study by each farmer 
using a questionnaire. One farmer reported a variation in his herd size 
of over 50 % during the study. This variation was included in the 
calculation of the number of cows (3360.5 cows in total). 
TIIMM =
∑
Intramammary AM injectors during lactation
DDDvet[UD/teat] × number of cows× observation period (days)
× 1000  
TIDRY =
∑
Intramammary AM injectors for dry off
DCDvet[UD/udder] × number of cows× observation period (days)
× 1000  
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TISYS =
∑
systemic AM for mastitis treatment (mg)
DDDvet × number of cows× kg per cow× observation period (days)
× 1000 
TI was calculated for each farm, antimicrobial product, and data 
source, respectively. Comparison of TIs between the different data 
sources was done at the level of overall sums over all farms. Number of 
injectors was also compared at the level of the individual farm. Indi-
vidual treatments could not be matched between the different data 
sources, because information on the treated animal and the date of 
treatment was only available in the treatment journal. In the practice 
software, dates of treatment were only available for treatments admin-
istered by the veterinarian. For garbage, only the month of treatment, 
and not the exact date was known. 
2.3.2. Statistical analysis 
For the statistical analysis at the level of the farm, only a subset of all 
antimicrobial products could be used. SYS were recorded in the veteri-
nary software and sometimes in the treatment journal, but very rarely in 
the garbage. Of 54 product used, 23 had to be excluded because they did 
not occur in all data sources. Furthermore, 21 products were used in less 
than 10 farms. For the 10 remaining IMM and DRY products, differences 
between the number of injectors for a given antimicrobial product and 
farm were compared between the four data sources. Statistical analyses 
were performed with STATA (StataCorp LCC, College Station, Texas, 
USA). First, the maximum number of injectors recorded in the four data 
sources in the respective farm was determined, assuming that it was 
more likely for a recording to be forgotten than for antimicrobials that 
had not been used to be falsely recorded. For each data source, the 
difference between the maximum number and the number in that data 
source was calculated. This was expressed as a relative error by dividing 
the difference by the maximum number recorded for that farm and 
product, respectively. The relative errors of the different data sources 
were compared with descriptive statistics. 
The relative errors had a bimodal distribution, with the peaks at 
values of 0 and 100 %. They were therefore classified into four cate-
gories. A relative error of 0 (corresponding to the maximum TI recorded 
in the respective data source) was classified as 0. An error >0 and less 
than 50 % was coded 1, 50 % to less than 100 % was coded 2, and an 
error of 100 % (corresponding to a completely missing entry in the 
respective data source) was coded 3. 
These error categories were further analysed in a mixed ordinal lo-
gistic regression model (Stata command meologit) with farm and 
product as random effects, and data source as fixed effect. Because this 
analysis requires a minimum sample size per cluster (Bell et al., 2010), 
we only included antimicrobial products, which had been used on at 
least 10 farms, and were present in all four data sources. 
In addition, TIs for all antimicrobial products were summed ac-
cording to their application (IMM, DRY and SYS) and the different WHO 
categories (HPCIAs, CIAs and HIAs). These sums were compared 
descriptively between the four data sources. Finally, the total number of 
different products found in the four data sources was compared. In the 
treatment journal, all registered antimicrobials used for udder health 
were included, irrespective of whether a dosage was given or not. 
Therefore, only three data sources were evaluated for the comparison of 
the total number of different products (software, garbage and treatment 
journal). 
3. Results 
Initially, 21 veterinary practices and 105 farms participated in the 
study. The antimicrobial consumption data of 20 veterinary practices 
and 92 farms could be analysed. Their geographical distribution was 
uneven within Switzerland, with most of them being located in the 
canton Berne. As one participating veterinarian left the practice during 
the study and the software data was consequently no longer available, 
this veterinary practice had to be excluded from the analysis. Of the 
remaining 100 farms, two changed their veterinarian, two stopped dairy 
farming during the intervention and one left the study. Moreover, one 
farmer did not store the garbage bags, resulting in only two collected 
bags within 18 months, one farmer refused to provide access to his 
treatment journal, and for another farmer the data of the treatment 
journal were obviously incomplete. These three farms were excluded 
from the final analysis. 
3.1. Data quality 
3.1.1. Data from practice software 
The software data of 49 and 43 farms could be extracted as Excel 
sheets and as PDF files, respectively. In total, 4249 entries could be 
clearly assigned to antimicrobials used for udder health. From these 
entries, 3991 (93.1 %) were further analysed and 258 (6.1 %) entries 
were considered implausible because of off-label use and therefore not 
included in the final analysis. 
3.1.2. Discarded drug packages from garbage bins 
On the 92 farms included in the analysis, 1656 garbage bags should 
have been gathered during the 18 months of collection period. In the 
end, 1646 garbage bags were collected, of which 1141 (69.3 %) bags 
contained discarded antimicrobial packages. 10 bags (0.6 %) could not 
be collected because they were lost by the farmers. 
One farmer did not replace the garbage bag at the beginning of every 
month and collected all antimicrobials in one garbage bag. However, as 
it is assumed that all discarded antimicrobial drug packages used for 
udder health were collected, the content of this unique garbage bag was 
included in the analysis. 
3.1.3. Treatment journal 
The treatment journal was either digital (50 farms) or paper based 
(41 farms). One farmer worked with both types of recordings. Alto-
gether, 2728 entries issued from treatment journals could be assigned to 
udder health. Out of these, 1444 (52.9 %) entries were complete and 
1284 (47.1 %) lacked at least one required data field, whereby large 
differences existed between the individual farmers regardless of whether 
the treatment journal was kept electronically or in paper form. As we 
only included antimicrobials that are registered for mastitis treatment, it 
was possible to supplement a total of 32 entries with missing indications 
as well as eight entries with missing cow identification numbers and 
prescription dates. As a result, a total of 1484 entries could be included 
in the recording of drugs from the treatment journal. Furthermore, a 
total of 1177 entries where the dosage was missing, but containing all 
other relevant information, could be supplemented with the dosage 
details issued from the Swiss Compendium of Veterinary Medicinal 
Products and used as treatment journal added. 
67 entries with missing drug names had to be completely discarded 
from the analysis (Table 1). Finally, a total of 2661 entries issued from 
the treatment journal added could be analysed. 
3.2. Comparison of antimicrobial quantities 
For every type of treatment (IMM, DRY and SYS), the highest 
recorded quantity of antimicrobials was reported with the veterinary 
practice software and the lowest quantity with the treatment journal. 
Almost as many udder injectors for IMM and DRY treatments were 
gathered with the garbage bags as were recorded with the veterinary 
practice software. However, a huge difference could be observed for the 
SYS group between the preparations recorded in the garbage bags 
compared to the software records. The treatment journal added recor-
ded the second-highest quantity for systemic preparations, but repre-
sented only slightly more than half of the quantity collected with the 
veterinary practice software (Table 2). 
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The differences between the recording systems were similar when TI 
was analysed separately for the different WHO categories (HPCIAs, CIAs 
and HIAs). 
Across all data sources, the highest quantity of IMM preparations 
were CIAs like penicillin, penicillin combinations as well as amino-
glycosides, followed by HPCIAs. Only a few preparations were assigned 
to the HIAs category (Fig. 1). 
On the other hand, no product containing HPCIAs was used in the 
DRY group (Fig. 2). Based on the analysis of the software and garbage 
data, CIAs were the most used dry off preparations. 
Regarding systemic preparations, the most frequently used antimi-
crobials belonged to the CIAs group. Similar to the overall distribution of 
systemic antimicrobials, most of CIAs were recorded with the practice 
software followed by the treatment journal added, the lowest quantity 
being recorded in the treatment journal. Conversely, the fewest HPCIAs, 
CIAs and HIAs were found in the garbage (Fig. 3). 
3.3. Comparison of the variety of products 
For both garbage and treatment journal, 23 IMM preparations and 10 
DRY preparations were collected. The lowest variety of intramammary 
preparations was found in the software (Table 3). 
Most of the systemic preparations were captured by the veterinary 
practice software (83.8 %), followed by the treatment journal (72.1 %) 
with the garbage (54.0 %) having the least. The widest variety of 
intramammary preparations was found in the garbage (88.5 % of IMM 
and 90.1 % of DRY), followed by the treatment journal (80.8 % of IMM 
and 90.1 % of DRY). The veterinary practice software captured only 69.2 
% and 63.6 % of the IMM and DRY preparations, respectively. 
Based on the number of different preparations present across all data 
Table 1 
Overview of entries in the treatment journal, how missing entries were handled and for which data source they could still be used.  
aOther = date, product or animal identification number. 
Table 2 
Comparison of antimicrobials quantities collected from different data sources.  
Data source Intramammary preparations 
Systemic preparations  
during lactation for dry off  
Quantity of 
injectors 
TI (DDD per 1000 cow- 
days) 
Quantity of 
injectors 
TI (DCD per 1000 cow- 
days) 
Quantity (in mg of active 
substances) 
TI (DDD per 1000 cow- 
days) 
Software 12,916.00 7.00 8,353 1.13 12,920,272 1.07 
Garbage 11,294.60 6.12 8,235 1.12 4,285,987 0.34 
Treatment journal 5,326.60 2.89 3,355 0.45 3,101,505 0.20 
Treatment journal 
added 
7,815.60 4.24 6,286 0.85 7,280,302 0.58 
TI: Treatment incidence. 
Software: Antimicrobial data extracted from veterinary practice software. 
Garbage: Discarded drug packages collected on farms. 
Treatment journal: Data from treatment journals collected on farms without supplemented missing dosage. 
Treatment journal added: Data from treatment journals collected on farms with the missing dosage records supplemented with information issued from the Swiss 
Compendium of Veterinary Medicinal Products. 
Fig. 1. Comparison of treatment incidence of intramammary 
antimicrobials used during lactation (TIIMM) according to WHO 
categorisation. 
DDD: Defined daily dose. 
Software: Antimicrobial data extracted from veterinary prac-
tice software. 
Garbage: Discarded drug packages collected on farms. 
Treatment journal: Data from treatment journals collected on 
farms without supplemented missing dosage. 
Treatment journal added: Data from treatment journals 
collected on farms with the missing dosage records supple-
mented with information issued from the Swiss Compendium 
of Veterinary Medicinal Products. 
HPCIAs: Highest Priority Critically Important Antimicrobials 
(according to WHO). 
CIAs: High Priority Critically Important Antimicrobials (ac-
cording to WHO). 
HIAs: Highly Important Antimicrobials (according to WHO).   
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sources, only 65.4 % and 63.6 % of intramammary preparations and 
44.4 % of systemic preparations were found in every data source. 
Consequently, preparations were found in the software that could not be 
found in the garbage or treatment journal and vice versa. 
Finally, the analysis of the data issued from the garbage and the 
treatment journal demonstrated the on-farm usage of intramammary 
antimicrobials, which are not approved in Switzerland for mastitis 
treatments and dry cow therapy (preparations from abroad). In the 
garbage, 23 of the 11294.6 injectors for intramammary treatment dur-
ing lactation and 4 of the 8235 injectors for dry cow therapy could be 
assigned to a product not approved in Switzerland. In the treatment 
journal, three entries out of a total of 2728 entries could be assigned to a 
preparation from abroad. 
3.4. Agreement of data sources on the farm level 
From 460 combinations of farm and antimicrobial product, the 
maximum number of injectors of all four data sources was recorded in 
the veterinary software in 258 combinations (56.1 %). In 231 combi-
nations, the maximum number was found in the garbage (50.2 %). In the 
Fig. 2. Comparison of treatment incidence of intramammary 
antimicrobials used for drying off (TIDRY) according to WHO 
categorisation. 
DCD: Defined course dose. 
Software: Antimicrobial data extracted from veterinary prac-
tice software. 
Garbage: Discarded drug packages collected on farms. 
Treatment journal: Data from treatment journals collected on 
farms without supplemented missing dosage. 
Treatment journal added: Data from treatment journals 
collected on farms with the missing dosage records supple-
mented with information issued from the Swiss Compendium 
of Veterinary Medicinal Products. 
CIAs: High Priority Critically Important Antimicrobials (ac-
cording to WHO). 
HIAs: Highly Important Antimicrobials (according to WHO).   
Fig. 3. Comparison of treatment incidence of systemic anti-
microbials used for mastitis treatment (TISYS) according to 
WHO categorisation. 
DDD: Defined daily dose. 
Software: Antimicrobial data extracted from veterinary prac-
tice software. 
Garbage: Discarded drug packages collected on farms. 
Treatment journal: Data from treatment journals collected on 
farms without supplemented missing dosage. 
Treatment journal added: Data from treatment journals 
collected on farms with the missing dosage records supple-
mented with information issued from the Swiss Compendium 
of Veterinary Medicinal Products. 
HPCIAs: Highest Priority Critically Important Antimicrobials 
(according to WHO). 
CIAs: High Priority Critically Important Antimicrobials (ac-
cording to WHO). 
HIAs: Highly Important Antimicrobials (according to WHO).   
Table 3 
Comparison of number of antimicrobial preparations collected from different data sources.  
Data source Intramammary preparations 
Systemic preparations  
during lactation for dry off  
recorded 
preparations 
% recorded 
preparations from 
abroad 
recorded 
preparations 
% recorded 
preparations from 
abroad 
recorded 
preparations 
% recorded 
preparations from 
abroad 
Software 18 69.23 0 7 63.64 0 31 83.78 0 
Garbage 23 88.46 3 10 90.91 1 20 54.05 0 
Treatment 
journal 
23 88.46 1 10 90.91 1 27 72.97 0 
Common in all 
data sources 
17 65.38 1 7 63.64 1 16 44.44 0 
Total different 
preparations 
26 100 3 11 100 1 36 100 0 
Garbage: Discarded drug packages collected on farms. 
Treatment journal: Data from treatment journals. 
Software: Antimicrobial data extracted from veterinary practice software. 
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treatment journal and treatment journal added, the maximum number 
was only recorded in 94 (20.4 %) and 56 (12.2 %) combinations, 
respectively. In 63 combinations (13.7 %), no treatment had been 
recorded in the practice software, even though usage of the product on 
the respective farm was recorded in another data source. Completely 
missing entries were found for 49 combinations (10.7 %) in the garbage, 
212 combinations (46.1 %) in the treatment journal, and 97 combina-
tions (21.1 %) in the treatment journal added. 
There was perfect agreement between garbage and veterinary soft-
ware in 258 combinations (56.1 %). Garbage agreed perfectly with 
treatment journal in 32 combinations (7.0 %), and with treatment 
journal added in 39 combinations (8.5 %). Veterinary software agreed 
perfectly with treatment journal in 32 combinations (7.0 %), and with 
treatment journal added in 39 combinations (8.5 %). Treatment journal 
and treatment journal added agreed perfectly with each other in 56 
combinations (12.2 %). 
The effect of the data source on the relative error category was 
further analysed with a mixed ordinal regression model. The random 
effect for product was not significant (chi-square for the likelihood ratio 
test = 1.9, p = 0.12, ICC = 0.007), and was therefore removed from the 
model. The random effect for farm was relatively small (0.16, 95 % CI 
0.08− 0.30), but significant (chi-square for the likelihood ratio 
test = 22.2, p < 0.001, ICC = 0.08). In a two-level model correcting for 
clustering on the level of the farm, treatment journal added was 
significantly less likely to be in a category with a greater relative error 
(OR = 0.4, 95 % CI = 0.3− 0.5) compared to treatment journal. Garbage 
(OR = 0.11, 95 % CI = 0.08− 0.14) and veterinary software (OR = 0.10, 
95 % CI = 0.07− 0.13) were also significantly less likely than the 
treatment journal to have a large relative error. 
4. Discussion 
The purpose of this study was to compare data on antimicrobial 
consumption between three different collection methods: treatment 
journal records, data from veterinary practice software and on-farm 
discarded drug packages. The highest antimicrobial consumption was 
recorded with the veterinary practice software. The lowest quantity was 
gathered with the treatment journal. The largest variety of intra-
mammary preparations was found with the garbage and the treatment 
journal. On the other hand, the veterinary practice software gathered 
most of the systemic preparations. 
4.1. Comparison of used quantity of antimicrobials 
As the current Swiss legislation requires a precise documentation of 
each antimicrobial treatment at farm level, treatment journals are assumed 
to reflect the integral AMU on farms. However, our results showed that the 
treatment journal recorded the lowest quantity of antimicrobials. This 
suggests that either the farmers or the veterinarians forgot to record entries 
in the treatment journals, and controls by the veterinary authorities failed 
to identify these missing data. Furthermore, this under-recording could be 
also due to poor compliance from the farmers’ side. In line with our results, 
previous studies suggested that the calculated AMU based on the treatment 
journal records was lower than the calculated AMU based on the data is-
sued from empty drug containers (Nobrega et al., 2017) as well as the 
antimicrobial data obtained from veterinary prescription records 
(Menéndez González et al., 2010; Kuipers et al., 2015). The comparably 
low antimicrobial quantity gathered with the treatment journal was partly 
due to the fact that the used dosage was missing in around half of the 
entries. Previous studies faced similar issues (Menéndez González et al., 
2010; Stevens et al., 2016; Nobrega et al., 2017). By supplementing the 
dosage with the information given in the Swiss Compendium of Veterinary 
Medicinal Products (treatment journal added), there might be a risk of 
over- or underestimation of the actual antimicrobial usage (Regula et al., 
2009; Echtermann et al., 2019). 
As prescribed antimicrobials are not necessarily used, antimicrobial 
sales or prescription data do not reflect the true AMU on farms. For this 
reason, the calculated treatment incidences based on the software data 
can possibly overestimate the actual AMU on farms. We tried to mini-
mise this bias by subtracting AM which had been returned from the 
farmer to their veterinarian. For intramammary preparations, the sec-
ond highest quantity was recorded by garbage bags. These preparations 
are usually prescribed and delivered by veterinarians after examination 
of diseased cows and administered by farmers themselves, who after-
wards dispose the discarded drug packages in these bags. However, this 
collection method could lead to an underestimation of the AMU if 
farmers did not discard the empty drug packages in the garbage bags. In 
particular, this might have happened if a diseased cow was treated 
directly by the veterinarian. Moreover, this could also explain the 
comparably low quantities of antimicrobials for systemic use collected 
in the garbage. Veterinarians routinely administer systemic antimicro-
bials themselves after examination of cows affected by acute mastitis. 
These antimicrobials are most of the time available in bottles containing 
volumes of either 50 mL or 100 mL (Swiss Compendium of Veterinary 
Medicinal Products, 2020). As veterinarians keep leftovers for the next 
antimicrobial treatment, some of these treatments could not be collected 
with the garbage. 
Based on the WHO categorisation of antimicrobials according to 
their importance for human health, the most frequently used intra-
mammary antimicrobials belonged to the category "critically important" 
(CIAs). Critically important substances like penicillin and penicillin 
combinations as well as aminoglycosides are in fact first-line antimi-
crobials for the treatment of acute mastitis (Antibiotika-Scout, 2020). 
The absence of dry off preparations belonging to the HPCIAs category is 
due to the fact that such preparations were neither available on the 
Swiss market (Swiss Compendium of Veterinary Medicinal Products, 
2020) nor imported from abroad. 
Similarly, the most frequently used systemic preparations belonged 
to the CIAs category. Substances of the category HPCIAs were the least 
frequently used systemic antimicrobials. As only a few HPCIAs prepa-
rations were found in the garbage, this suggests that veterinarians are 
mostly administering these products themselves. 
4.2. Comparison of preparations 
Surprisingly, the widest variety of intramammary preparations was 
found in the garbage and in the treatment journal. As a veterinary 
medicines contract was a prerequisite for the participation to the study, 
which ensures that only one veterinary practice supplies the farmer with 
antimicrobial preparations, the authors expected to find the same 
intramammary preparations in every data source. However, during 
emergency services, a different veterinary practice may treat the cows. 
Moreover, a few intramammary antimicrobial preparations were 
recorded, which are not approved in Switzerland for mastitis or dry off 
treatments, but contain antimicrobial substances which can legally be 
used in dairy cows. The occasional acquisition of those drugs from 
abroad (France) is a commonly known practice among the sector 
(Pucken et al., 2019). As the number of different intramammary prep-
arations found in the software was lower than the number found in 
garbage and treatment journal, the calculated antimicrobial consump-
tion based on the veterinary software might underestimate the use of 
intramammary preparations. 
In contrast to intramammary preparations, systemic preparations are 
usually prescribed and used by the contractual veterinarian after ex-
amination of diseased cows. This explains that the widest variety of 
these preparations was gathered with the veterinary practice software. 
The lowest systemic preparations variety was found in the garbage and 
in the treatment journal. Therefore, the calculated AMU based on both 
methods might underestimate the use of systemic preparations. 
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4.3. Strengths and limitations 
This study had to rely on the voluntary participation of a small 
number of veterinary practices and dairy farms. This selection bias was 
unavoidable, as the support of farmers and veterinarians was needed to 
conduct the study. Since the participants were interested in the study, 
they might be more likely to record antimicrobial treatments accurately, 
and therefore have data quality above-average. We also had to exclude 
farmers with very poor recordings, and records with implausible data. 
Volunteer farmers and veterinarians might use antimicrobials more 
prudently than those who chose not to participate, resulting in a lower 
antimicrobial consumption. For the farmers, this bias is likely to be small 
because of the high participation rate for this study. This descriptive 
study is not representative of the population and the results on antimi-
crobial usage cannot be extrapolated to the Swiss dairy production. 
4.4. Data quality 
Despite the mandatory documentation of antimicrobial treatments at 
farm level in Switzerland, the recorded data from farm treatment jour-
nals were often inaccurate and incomplete: around half of the entries 
lacked at least one piece of critical information. 
The collection of discarded drug packages with the help of garbage 
bags was convenient and easy to implement. Around 30 % of the pro-
vided garbage bags were discarded at collection, suggesting no AMU 
during the respective month. Even though it cannot be excluded that 
farmers forgot to put some of the discarded antimicrobial packages into 
these bags, this collection method on AMU seems to be reliable for DRY 
and SYS, and is recommended by the authors of previous studies (Carson 
et al., 2008; Saini et al., 2012). 
As a moderate number of entries issued from veterinary practice 
software had to be excluded from the analysis, it is assumed that the 
software data were more complete than data collected with the other 
methods (Kuipers et al., 2015). The different software systems used were 
not mutually compatible, making the data extraction difficult and 
complex. Hence, this emphasises the need of a standardised system to 
quantify and assess the antimicrobial consumption at practice and farm 
level. 
4.5. Future perspectives and implications 
The results of this study show that the collection of antimicrobial 
data with the garbage bin could be an appropriate tool to record anti-
microbials administered by farmers. This method could detect use of 
preparations which were not prescribed by contractual veterinarians as 
well as preparations which are not approved in Switzerland for the 
indication mastitis. 
In contrast, the recording of AMU by the farmer in a treatment 
journal seems to considerably underestimate usage. There were huge 
discrepancies in data completeness between the participating farms. 
Therefore, this method cannot be recommended for collecting data on 
AMP or AMU for benchmarking or monitoring purposes. 
Finally, the results of this study further emphasise the need of 
implementing a standardised system to record antimicrobial treatments 
at individual animal and farm level. In Switzerland, one step towards 
this need was completed in 2019 with the implementation of the In-
formation System Antimicrobials in Veterinary Medicine (IS ABV). 
Within this system, veterinary practices and clinics have to record data 
on AMP for individual and group therapies in a standardised format into 
a central database. The database contains information on animal spe-
cies, age class and production type, number of treated animals, anti-
microbial drug, dosage and diagnosis or indication for treatment. This 
allows for calculation of standardised measures of treatment intensity 
such as prescribed daily dose or defined daily dose (DDDvet) (European 
Surveillance of Veterinary Antimicrobial Consumption (ESVAC), 2016). 
Therefore, treatment intensity can be compared among different animal 
species and age classes (Federal Food Safety and Veterinary Office, 
2020). 
5. Conclusion 
The results of this study demonstrate a significant lack of data con-
sistency between three different collection methods. No single collection 
method was able to capture the integrity of data on AMU in the 
participating farms. As a standardised monitoring system with central-
ized data analysis, the newly launched Information System Antimicro-
bials in Veterinary Medicine (IS ABV) can provide a better 
understanding of AMP at farm and veterinary practice level in 
Switzerland. Data quality is a critical aspect of such a system, because it 
is unlikely that one single recording method is going to represent the 
total quantity of antimicrobial usage. 
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